Microglial activation states and their implications for Alzheimer's Disease

Jan 12, 2025The journal of prevention of Alzheimer's disease

Different types of immune cell activity in the brain and their links to Alzheimer's Disease

AI simplified

Circadian Biology on OpenScience ↗PubMed ↗DOI ↗

Abstract

Alzheimer's Disease (AD) is characterized by the accumulation of toxic amyloid-beta plaques and tau protein tangles in the brain.

Microglia, the brain's immune cells, initially clear amyloid-beta but become overwhelmed in AD, leading to harmful neuroinflammation.
Chronic activation of microglia can enhance plaque toxicity and create a damaging cycle affecting neurons and other brain cells.
Inflammatory responses triggered by amyloid-beta can produce reactive oxygen species and inflammatory cytokines, contributing to cognitive decline.
Activated microglia can exhibit both pro-inflammatory and anti-inflammatory states, with significant overlap between these responses.
Inducing anti-inflammatory states may provide a therapeutic strategy to address both neuroinflammation and plaque accumulation in AD.

AI simplified

Alzheimer's Disease (AD) is a chronic neurodegenerative disorder characterized by the accumulation of toxic amyloid-beta (Aβ) plaques and neurofibrillary tangles (NFTs) of tau protein in the brain. Microglia, key immune cells of the central nervous system, play an important role in AD development and progression, primarily through their responses to Aβ and NFTs. Initially, microglia can clear Aβ, but in AD, chronic activation overwhelms protective mechanisms, leading to sustained neuroinflammation that enhances plaque toxicity, setting off a damaging cycle that affects neurons, astrocytes, cerebral vasculature, and other microglia. Current AD treatments have been largely ineffective, though emerging immunotherapies focusing on plaque removal show promise, but often overlook the role of neuroinflammation. Activated microglia display a complex range of phenotypes that can be broadly broken into pro- or anti-inflammatory states, although this dichotomy does not describe the significant overlap between states. Aβ can strongly induce inflammatory activity, triggering the production of reactive oxygen species, inflammatory cytokines (e.g., TNF-α, IL-1β, IL-6), synapse engulfment, blood-brain barrier compromise, and impaired Aβ clearance. These processes contribute to neural tissue loss, manifesting as cognitive decline such as impaired executive function and memory. Conversely, anti-inflammatory activation exerts neuroprotective effects by suppressing inflammatory pathways and releasing neurotrophic factors that aid neuron repair and protection. Induction of anti-inflammatory states may offer a dual therapeutic approach to address both neuroinflammation and plaque accumulation in AD. This approach suggests potential strategies to modulate microglial phenotypes, aiming to restore neuroprotective functions and mitigate disease progression by simultaneously targeting inflammation and plaque pathology.

Full Text

We can’t show the full text here under this license. Use the link below to read it at the source.

View full text (XML) ↗View full text ↗

Microglial activation states and their implications for Alzheimer's Disease

Abstract

Full Text

You found one interesting study. We’ll send the next 7.

what lands in your inbox each week:

Recent issues from the circadian biology brief

Abstract

Full Text

Related papers

You found one interesting study. We’ll send the next 7.

what lands in your inbox each week:

Recent issues from the circadian biology brief